stock here: FLCCC was a leader in COVID treatment.
They still lead. And below is one of their articles on the danger of the spike protein
Last week, our Dr. Paul Marik, Chief Scientific Officer of the FLCCC, sat down with Jan Jekielek, host of Epoch TV’s American Thought Leaders and Senior Editor at The Epoch Times, for a discussion on the suppression of early treatment for COVID-19, increasing spike protein-induced diseases, and so much more.
“The spike protein is probably one of the most toxic proteins the human body has ever seen,” said Dr. Marik. “If you have long COVID, you absolutely want to avoid being vaccinated.”
During the interview, Dr. Marik also discussed the abject failure of many high-impact medical journals to publish factual, data-driven research studies, noting that, “I used to think that what I read in the medical journals was the truth. Now I know it is completely false.”
Mr. Jekielek’s expert interview of Dr. Marik — the nation’s most highly published Critical Care physician — is intense, riveting and soul-searing; bringing viewers deep inside the battle to rescue medical ethics from the clutches of ruthless paymasters.
A MUST READ ABOUT SPIKE PROTEIN DISEASES
In this new and meticulously detailed report, Epoch Times reporter Marina Zhang writes about how spike protein disrupts immunity in millions post-COVID infection or vaccination. She interviewed several physicians (including Dr. Kory and Dr. Marik) who are on the front lines of developing treatment protocols for conditions related to spike protein diseases. Zhang writes:
“Multiple studies have shown that the SARS-CoV-2 spike protein is a highly toxic and inflammatory protein, capable of causing pathologies in its hosts. The presence of spike protein has been strongly linked with long COVID and post-vaccine symptoms. Studies have shown that spike proteins are often present in symptomatic patients, sometimes even months after infections or vaccinations.
Many doctors are looking to change this situation. The FLCCC has been at the forefront in treating COVID-19, long COVID, and post-vaccine symptoms”
Jan Jekielek also interviewed Dr. Ryan Cole, who discussed the alarming rise of “wildfire cancers” and the dangers of the spike protein. Watch that interview HERE.
OMG. You just HAVE to read Alexandros Marinos’ most recent Substack essay. It’s HERE.
This essay reads like a true crime story—except that it would be impossible to rope off the crime scene with yellow caution tape because it would need to circumnavigate the globe.
Marinos’ Substack (aptly named “Do Your Own Research”) pulls back the curtain on the now ubiquitous practice of high-impact medical journals publishing pure, unadulterated, not-really-science-at-all rubbish. Junk science. Made-up medicine. Rotten refuse that can—and has been — deadly to millions around the world. This is especially true when it comes to ivermectin and other repurposed drugs. It matters little to these purveyors of pernicious publications that rigorous science has shown over and over again that many of these drugs are exceedingly efficacious in every phase of COVID-19 disease. But once again, there are paymasters to whom they must bow and profits that must grow to rival the girth of oceans.
From Mr. Marinos’ essay on why the new NIH-funded Randomized Controlled Trial published recently was so horrifically flawed:
- The drugs were sent to the patients by mail, so that some patients took them 13 or 14 days after symptom onset.
- The authors never saw the vast majority of the patients, and every step of the process was done remotely. They call this a “distributed” trial.
- There is no reporting of adherence in the trial, so we don’t even know how many of the patients took how many of the doses they were given.
- There is no per-protocol analysis, so we don’t know how well the drug did in the patients who actually took all the doses.
And still, the results are actually strongly positive for ivermectin, if you strip back the bias.
Once you’ve finished reading the entire essay, share it with the world. Really. Do it. Thanks.